Phibro Animal Health (NASDAQ:PAHC) was upgraded by investment analysts at ValuEngine from a “sell” rating to a “hold” rating in a note issued to investors on Thursday, ValuEngine reports.

A number of other analysts also recently weighed in on the company. Zacks Investment Research downgraded Phibro Animal Health from a “hold” rating to a “sell” rating in a research report on Tuesday, April 23rd. BidaskClub upgraded Phibro Animal Health from a “sell” rating to a “hold” rating in a research report on Friday, March 22nd. Gabelli upgraded Phibro Animal Health from a “hold” rating to a “buy” rating and set a $42.00 target price for the company in a research report on Wednesday, May 8th. They noted that the move was a valuation call. Finally, Guggenheim assumed coverage on Phibro Animal Health in a research report on Thursday. They issued a “neutral” rating for the company. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average price target of $43.50.

Shares of NASDAQ PAHC opened at $29.74 on Thursday. Phibro Animal Health has a 12 month low of $28.26 and a 12 month high of $54.62. The company has a quick ratio of 1.98, a current ratio of 3.41 and a debt-to-equity ratio of 1.48. The stock has a market cap of $1.20 billion, a PE ratio of 17.09, a price-to-earnings-growth ratio of 4.35 and a beta of 0.63.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings data on Monday, May 6th. The company reported $0.39 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.43 by ($0.04). Phibro Animal Health had a return on equity of 33.77% and a net margin of 8.12%. The business had revenue of $205.70 million for the quarter, compared to analysts’ expectations of $214.94 million. During the same period in the previous year, the firm posted $0.46 EPS. The firm’s revenue for the quarter was down 1.5% compared to the same quarter last year. Sell-side analysts anticipate that Phibro Animal Health will post 1.52 EPS for the current year.

Large investors have recently added to or reduced their stakes in the stock. Truvestments Capital LLC bought a new stake in Phibro Animal Health in the 1st quarter worth approximately $36,000. Quantamental Technologies LLC bought a new stake in Phibro Animal Health in the 4th quarter worth approximately $60,000. Advisory Services Network LLC lifted its position in Phibro Animal Health by 20.4% in the 4th quarter. Advisory Services Network LLC now owns 2,195 shares of the company’s stock worth $71,000 after buying an additional 372 shares during the last quarter. Advisors Asset Management Inc. lifted its position in Phibro Animal Health by 52.3% in the 4th quarter. Advisors Asset Management Inc. now owns 2,536 shares of the company’s stock worth $82,000 after buying an additional 871 shares during the last quarter. Finally, Advisor Group Inc. lifted its position in Phibro Animal Health by 40.2% in the 1st quarter. Advisor Group Inc. now owns 2,596 shares of the company’s stock worth $85,000 after buying an additional 745 shares during the last quarter. Institutional investors own 50.87% of the company’s stock.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.

Recommended Story: Google Finance Portfolio Tips and Tricks

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.